Abstract
Introduction: In recent years, resting-state functional magnetic resonance imaging (rsfMRI) has been increasingly used as a noninvasive and practical method in different areas of neuroscience and psychology for recognizing brain’s mechanism as well as diagnosing neurological diseases. In this work, we use rs-fMRI data for diagnosing Alzheimer's disease.
Materials and Methods: To do that, by using the rs-fMRI of a patient, we computed the time series of some anatomical regions and then applied the Latent Low Rank Representation method to extract suitable features. Next, based on the extracted features, we apply a Support Vector Machine (SVM) classifier to determine whether the patient belongs to a healthy category, mild stage of the disease or Alzheimer's stage.
Results: The obtained classification accuracy for the proposed method is more than 97.5%.
Conclusion: We performed different experiments on a database of rs-fMRI data containing the images of 43 healthy subjects, 36 mild cognitive impairment patients and 32 Alzheimer’s patients and the obtained results demonstrated that the best performance is achieved when the SVM with Gaussian kernel and the features of only 7 regions were used.
Keywords: Functional magnetic resonance imaging (fMRI), alzheimer disease, resting-state network, latent low rank representation, SVM.
Current Signal Transduction Therapy
Title:Alzheimer Disease Diagnosis from fMRI Images Based on Latent Low Rank Features and Support Vector Machine (SVM)
Volume: 16 Issue: 2
Author(s): Nastaran Shahparian, Mehran Yazdi*Mohammad Reza Khosravi
Affiliation:
- School of Electrical and Computer Engineering, Shiraz University,Iran
Keywords: Functional magnetic resonance imaging (fMRI), alzheimer disease, resting-state network, latent low rank representation, SVM.
Abstract:
Introduction: In recent years, resting-state functional magnetic resonance imaging (rsfMRI) has been increasingly used as a noninvasive and practical method in different areas of neuroscience and psychology for recognizing brain’s mechanism as well as diagnosing neurological diseases. In this work, we use rs-fMRI data for diagnosing Alzheimer's disease.
Materials and Methods: To do that, by using the rs-fMRI of a patient, we computed the time series of some anatomical regions and then applied the Latent Low Rank Representation method to extract suitable features. Next, based on the extracted features, we apply a Support Vector Machine (SVM) classifier to determine whether the patient belongs to a healthy category, mild stage of the disease or Alzheimer's stage.
Results: The obtained classification accuracy for the proposed method is more than 97.5%.
Conclusion: We performed different experiments on a database of rs-fMRI data containing the images of 43 healthy subjects, 36 mild cognitive impairment patients and 32 Alzheimer’s patients and the obtained results demonstrated that the best performance is achieved when the SVM with Gaussian kernel and the features of only 7 regions were used.
Export Options
About this article
Cite this article as:
Shahparian Nastaran, Yazdi Mehran *, Khosravi Reza Mohammad , Alzheimer Disease Diagnosis from fMRI Images Based on Latent Low Rank Features and Support Vector Machine (SVM), Current Signal Transduction Therapy 2021; 16 (2) . https://dx.doi.org/10.2174/1574362414666191202144116
DOI https://dx.doi.org/10.2174/1574362414666191202144116 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Blood-based Amyloid and Tau Biomarker Tests For Alzheimer’s Disease
Neuroscience and Biomedical Engineering (Discontinued) Reducing the Risk of Major Elective Non-cardiac Surgery: Is there a Role for Levosimendan in the Preoperative Optimization of Cardiac Function?
Current Drug Targets Methamphetamine Induces Striatal Cell Death Followed by the Generation of New Cells and a Second Round of Cell Death in Mice
Current Neuropharmacology Berberine Alleviates Amyloid-beta Pathogenesis Via Activating LKB1/AMPK Signaling in the Brain of APP/PS1 Transgenic Mice
Current Molecular Medicine Glutamate NMDA Receptor Antagonists with Relevance to Schizophrenia: A Review of Zebrafish Behavioral Studies
Current Neuropharmacology Perspectives on Developing Small Molecule Inhibitors Targeting HIV-1 Integrase
Mini-Reviews in Medicinal Chemistry Cognitive Behavioral Therapy in Prodromal Psychosis
Current Pharmaceutical Design Voltammetric Sensing of Uremic Toxin Indoxyl Sulfate Using High Performance Disposable Screen-Printed Graphene Electrode
Current Pharmaceutical Analysis Possible Involvement of Muscarinic Receptors in Psychiatric Disorders: A Focus on Schizophrenia and Mood Disorders
Current Molecular Medicine Brucella Pneumonia with Systemic Complications and Pancytopenia: A Case Report
Infectious Disorders - Drug Targets Editorial [ Hot Topic:Magic Bullets and Arrows: Biologic Approaches to Treat Substance Use Disorders (Guest Editor: Phil Skolnick and Nora D. Volkow)]
CNS & Neurological Disorders - Drug Targets Design and Development of Molecular Imaging Probes
Current Topics in Medicinal Chemistry PDE5 Inhibitors: In Vitro and In Vivo Pharmacological Profile
Current Pharmaceutical Design Matter of Life and Death: the Pharmacological Approaches Targeting Apoptosis in Brain Diseases
Current Pharmaceutical Design New Inotropic Pharmacologic Strategies Targeting the Failing Myocardiumin the Newborn and Infant
Mini-Reviews in Medicinal Chemistry The IFN-λ Family (IL-28/29)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Role of the Region 23-28 in Aβ Fibril Formation: Insights from Simulations of the Monomers and Dimers of Alzheimers Peptides Aβ40 and Aβ42
Current Alzheimer Research Editorial: (Thematic Issue Genetic Factors in Parkinson’s Disease)
Current Genomics Loneliness in Adolescence – A Two-Systems Approach
Adolescent Psychiatry CSF Ubiquitin As a Specific Biomarker in Alzheimer's Disease
Current Alzheimer Research